Melting Point Distribution Analysis of Globally Approved and Discontinued Drugs: A Research for Improving the Chance of Success of Drug Design and Discovery

ChemistryOpen

Volumn 5, Issue 4, 2016, Pages 357-368

  Mao, Fei ^a   Kong, Qingya ^a   Ni, Wei ^a   Xu, Xiang ^a   Ling, Dazheng ^a   Lu, Zhengyu ^a   Li, Jian ^a  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

approved drugs; discontinued drugs; drug design and discovery; drug like properties; Lipinski s rule of five; melting point distribution

Indexed keywords

DATABASE SYSTEMS; MOLECULES;

APPROVED DRUG; DISCONTINUED DRUG; DISTRIBUTION ANALYSIS; DRUG DESIGN; DRUG DISCOVERY; DRUG-LIKE PROPERTY; LIPINSKI′S RULE OF FIVE; MELTING POINT DISTRIBUTION; ORGANIC SMALL MOLECULE; PROPERTY;

MELTING POINT;

EID: 84961892047     PISSN: None     EISSN: 21911363     Source Type: Journal    
DOI: 10.1002/open.201600015     Document Type: Article

References (27)

1. D. Cook, D. Brown, R. Alexander, R. March, P. Morgan, G. Satterthwaite, M. N. Pangalos, Nat. Rev. Drug Discov. 2014, 13, 419–431.
2. M. J. Waring, J. Arrowsmith, A. R. Leach, P. D. Leeson, S. Mandrell, R. M. Owen, G. Pairaudeau, W. D. Pennie, S. D. Pickett, J. Wang, O. Wallace, A. Weir, Nat. Rev. Drug Discov. 2015, 14, 475–486.
3. C. A. Lipinski, F. Lombardo, B. W. Dominy, P. J. Feeney, Adv. Drug Delivery Rev. 1997, 23, 3–25.
4. D. F. Veber, S. R. Johnson, H.-Y. Cheng, B. R. Smith, K. W. Ward, K. D. Kopple, J. Med. Chem. 2002, 45, 2615–2623.
5. P. D. Leeson, A. M. Davis, J. Med. Chem. 2004, 47, 6338–6348.
6. T. I. Oprea, J. Comput. Aid. Mol. Des. 2000, 14, 251–64.
7. D. T. Manallack, R. J. Prankerd, E. Yuriev, T. I. Oprea, D. K. Chalmers, Chem. Soc. Rev. 2013, 42, 485–496.
8. M. Congreve, R. Carr, C. Murray, H. Jhoti, Drug Discovery Today 2003, 8, 876–877.
9. M. C. Wenlock, R. P. Austin, P. Barton, A. M. Davis, P. D. Leeson, J. Med. Chem. 2003, 46, 1250–1256.
10. C. A. Lipinski, F. Lombardo, B. W. Dominy, P. J. Feeney, Adv. Drug Delivery Rev. 2001, 46, 3–26.
11. D. E. Clark, S. D. Pickett, Drug Discovery Today Drug Discov. Today 2000, 5, 49–58.
12. H. Pajouhesh, G. R. Lenz, NeuroRx 2005, 2, 541–553.
13. J. Kelder, P. D. J. Grootenhuis, D. M. Bayada, L. P. C. Delbressine, J. P. Ploemen, Pharm. Res. 1999, 16, 1514–1519.
14. T. J. Ritchie, C. N. Luscombe, S. J. F. Macdonald, J. Chem. Inf. Model. 2009, 49, 1025–1032.
15. Y. B. Choy, M. R. Prausnitz, Pharm. Res. 2011, 28, 943–948.
16. M. Vieth, M. G. Siegel, R. E. Higgs, I. A. Watson, D. H. Robertson, K. A. Savin, G. L. Durst, P. A. Hipskind, J. Med. Chem. 2004, 47, 224–232.
17. M. Rask-Andersen, M. S. Almen, H. B. Schioth, Nat. Rev. Drug Discovery 2011, 10, 579–590.
18. M. Vieth, J. J. Sutherland, J. Med. Chem. 2006, 49, 3451–3453.
19. A. L. Hopkins, C. R. Groom, A. Alex, Drug Discovery Today 2004, 9, 430–431.
20. P. D. Leeson, B. Springthorpe, Nat. Rev. Drug Discovery 2007, 6, 881–890.
21. P. N. Mortenson, C. W. Murray, J. Comp. Aid. Mol. Des. 2011, 25, 663–667.
22. J. W. Nissink, J. Chem. Inf. Model. 2009, 49, 1617–1622.
23. M. D. Shultz, Bioorg. Med. Chem. Lett. 2013, 23, 5980–5991.
24. S. H. Yalkowsky, S. C. Valvani, J. Pharm. Sci. 1980, 69, 912–22.
25. J. C. Dearden, Sci. Total Environ. 1991, 109–110, 59–68.
26. N. Jain, S. H. Yalkowsky, J. Pharm. Sci. 2001, 90, 234–52.
27. C. R. Chong, D. J. Sullivan, Nature 2007, 448, 645–6.